The global market for Stem Cell Technologies is forecast to reach US$29.3 billion by 2024, driven by factors such as continuous discovery of new sources of stem cells, innovative new methods for their acquisition and harvesting, increasing incidence of chronic diseases, rising demand for regenerative medicine, and robust investments in healthcare R&D. Potential applications for human stem cells range from cell and tissue generation to testing new drugs for safety. Currently, over ten stem cell therapies have been approved globally with stem cell based bone marrow transplant being the most widely used. The United States represents the largest market worldwide supported by huge government funding and the ensuing increase in the number of stem cell clinical trials underway. Asia-Pacific ranks as the fastest growing market led by factors such as growing interest of Southeast Asian countries in understanding and commercializing stem cells for a range of crippling and degenerative diseases; policy led development of networking infrastructure for stem cell research, stem cell banking and stem cell tourism; adoption of free enterprise model by Asian countries to encourage public and private funding and participation; and growing focus on life sciences research to manage the growing healthcare burden in the region.  

Download Free Sample Pages of this report

Summary of Findings
  • Raging Scientific Controversies Surrounding the Effectiveness of the Predictive Power of Animal Models in Drug Discovery Drives Use of Stem Cells in Drug Screening, Discovery and Development
  • Ethical Issues Surrounding Embryonic Stem Cells Drives Research Focus on Adult Stem Cells Harvested from Brain, Bone Marrow, Blood Vessels, Skeletal Muscle, Skin, Heart and Liver
  • Unmet medical Needs in the Treatment of Macular Degeneration, Heart Disease, Osteoarthritis and Rheumatoid Arthritis Drive Commercialization Opportunities for Cell-Based Therapies
  • Ongoing Research for Harvesting Stem-Cell Derived Insulin-Producing Beta Cells Infuses Optimism in Future Stem Cell Based Treatment for Diabetes
  • Japan and the United States: Pioneers in Induced Pluripotent Stem Cell (iPSC) Research

Timeline for Analysis
  • Market Estimates and Forecasts for 2016-2024

Geographic Markets Analyzed
  • US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, and Rest of Europe), Asia-Pacific (China, and Rest of Asia-Pacific), Latin America (Brazil, and Rest of Latin America), and Rest of World

Major Players
  • Athersys, Inc.
  • Apceth GmbH & Co.KG
  • AVIVA BioSciences Corporation
  • BioE, Inc.
  • Bone Therapeutics SA
  • Cesca Therapeutics, Inc.
  • Cryo-Cell International, Inc.
  • Cytori Therapeutics, Inc.

How Can You Benefit?
This research project broadly covers analysis of all market trends, drivers, challenges and other macro market scenarios you need to know to improve your strategic planning and remain informed and competitive. The study also provides reliable ready facts and exclusive statistical data insights in addition to expert and highly accurate market size forecasts and projections to help you identify new markets and opportunities for revenue growth and sustainability. The extensive reportage of industry, company and product news and stories together with coverage of all major and niche players provided in the report helps you build a 360 degree perspective on your markets and gain unsurpassed insights needed to devise plans and strategies to maximize business growth.